JP2013534814A5 - - Google Patents

Download PDF

Info

Publication number
JP2013534814A5
JP2013534814A5 JP2013512703A JP2013512703A JP2013534814A5 JP 2013534814 A5 JP2013534814 A5 JP 2013534814A5 JP 2013512703 A JP2013512703 A JP 2013512703A JP 2013512703 A JP2013512703 A JP 2013512703A JP 2013534814 A5 JP2013534814 A5 JP 2013534814A5
Authority
JP
Japan
Prior art keywords
rhamm
binding peptide
seq
probe
label
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013512703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013534814A (ja
JP6153467B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2011/000613 external-priority patent/WO2011150495A1/en
Publication of JP2013534814A publication Critical patent/JP2013534814A/ja
Publication of JP2013534814A5 publication Critical patent/JP2013534814A5/ja
Application granted granted Critical
Publication of JP6153467B2 publication Critical patent/JP6153467B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013512703A 2010-05-31 2011-05-31 Rhamm結合ペプチド Expired - Fee Related JP6153467B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34997010P 2010-05-31 2010-05-31
US61/349,970 2010-05-31
PCT/CA2011/000613 WO2011150495A1 (en) 2010-05-31 2011-05-31 Rhamm binding peptides

Publications (3)

Publication Number Publication Date
JP2013534814A JP2013534814A (ja) 2013-09-09
JP2013534814A5 true JP2013534814A5 (https=) 2015-03-19
JP6153467B2 JP6153467B2 (ja) 2017-06-28

Family

ID=45066087

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013512703A Expired - Fee Related JP6153467B2 (ja) 2010-05-31 2011-05-31 Rhamm結合ペプチド

Country Status (9)

Country Link
US (2) US9090659B2 (https=)
EP (2) EP2576597A4 (https=)
JP (1) JP6153467B2 (https=)
KR (1) KR101947529B1 (https=)
CN (2) CN106188270A (https=)
AU (1) AU2011261107B2 (https=)
CA (1) CA2801237A1 (https=)
RU (1) RU2012157597A (https=)
WO (1) WO2011150495A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014082042A2 (en) 2012-11-25 2014-05-30 The Regents Of The University Of California Peptides that stimulate subcutaneous adipogenesis
WO2015184125A1 (en) 2014-05-28 2015-12-03 The Regents Of The University Of California Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
US10562935B2 (en) 2015-03-20 2020-02-18 London Health Sciences Centre Research Inc. Stapled peptides and uses thereof
WO2017186855A1 (en) * 2016-04-28 2017-11-02 Forschungsverbund Berlin E.V. Unusual substrates of tubulin tyrosine ligase
KR102524369B1 (ko) * 2020-08-14 2023-04-20 연세대학교 산학협력단 플루오레세인에 결합하는 펩타이드, 이를 암호화하는 핵산 분자, 단백질 발현 벡터, 이를 이용한 바이오 진단 프로브 및 바이오 진단 키트

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4714681A (en) 1981-07-01 1987-12-22 The Board Of Reagents, The University Of Texas System Cancer Center Quadroma cells and trioma cells and methods for the production of same
US4716111A (en) 1982-08-11 1987-12-29 Trustees Of Boston University Process for producing human antibodies
US4713325A (en) 1983-06-14 1987-12-15 The Regents Of The University Of California Hybridomas producing monoclonal antibodies specific for FeLV p27
US4716117A (en) 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
CA1207852A (en) 1984-02-29 1986-07-15 William D. Cornish Non-resonant microwave frequency halver
US4762915A (en) 1985-01-18 1988-08-09 Liposome Technology, Inc. Protein-liposome conjugates
US4720459A (en) 1985-02-14 1988-01-19 Medical College Of Wisconsin Research Foundation, Inc. Myelomas for producing human/human hybridomas
GB9207949D0 (en) 1992-04-09 1992-05-27 Univ Manitoba Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
US5824315A (en) 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
GB9420740D0 (en) 1994-10-14 1994-11-30 Univ Manitoba Sequence of the hyaluronan receptor gene
CA2166155C (en) 1995-12-27 2008-02-05 Eva Anne Turley Agents binding to hyaluronic acid binding domains and the use thereof
GB9607441D0 (en) 1996-04-10 1996-06-12 Univ Manitoba Human hyaluronan receptor
IL120561A0 (en) 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
CA2237051A1 (en) 1997-12-19 1999-06-19 Eva A. Turley Enhanced affinity hyaluronan binding peptides
WO2000029447A1 (en) 1998-11-19 2000-05-25 Smithkline Beecham Corporation Rhamm antagonist antibodies
US6864235B1 (en) 1999-04-01 2005-03-08 Eva A. Turley Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
US6911429B2 (en) 1999-04-01 2005-06-28 Transition Therapeutics Inc. Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
US20030050236A1 (en) * 2000-08-15 2003-03-13 The University Of Chicago Compounds that enhance tumor death
JP4210746B2 (ja) * 2003-05-12 2009-01-21 独立行政法人農業生物資源研究所 葯特異的遺伝子および該遺伝子のプロモーター、並びにそれらの利用
EP1750706B1 (en) 2004-06-01 2016-10-05 University Of Virginia Patent Foundation Dual small molecule inhibitors of cancer and angiogenesis
JP2008522624A (ja) * 2004-12-09 2008-07-03 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘミアスタリン(hemiasterlin)アナログを使用する癌治療におけるチューブリンのアイソタイプのスクリーニング
US20060154312A1 (en) 2004-12-09 2006-07-13 Sergei Agoulnik Tubulin isotype screening in cancer therapy using halichondrin B analogs
EP2126580A4 (en) 2005-02-10 2010-11-10 Cell Signaling Technology Inc REAGENTS FOR DETECTING PROTEIN PHOSPHORYLATION IN LEUKEMIA SIGNAL PATHS
WO2007046796A1 (en) * 2005-10-19 2007-04-26 Creighton University Peptides and methods of use
WO2008140587A2 (en) * 2006-11-21 2008-11-20 The Regents Of The University Of California Rhamm, a co-receptor and its interactions with other receptors in cancer cell motility and the identification of cancer prognitor cell populations
US20100062000A1 (en) 2006-11-21 2010-03-11 The Regents Of The University Of California Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations
WO2008138916A1 (en) 2007-05-10 2008-11-20 Pronota N.V. Isolation of peptides and proteomics platform
WO2009046530A1 (en) 2007-10-12 2009-04-16 London Health Sciences Centre Research Inc. Compositions affecting hyaluronic acid mediated activity
US20090220991A1 (en) 2008-02-29 2009-09-03 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in leukemia signaling pathways
WO2010115141A2 (en) * 2009-04-02 2010-10-07 New York University System and uses for generating databases of protein secondary structures involved in inter-chain protein interactions
US20130157285A1 (en) 2011-10-12 2013-06-20 The Regents Of The University Of California Identification of invasive and slow-growing tumorigenic cell subsets in tumors

Similar Documents

Publication Publication Date Title
JP6789823B2 (ja) 両末端peg化インテグリン結合性ペプチドおよびその使用方法
Gupta et al. Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management
JP2013534814A5 (https=)
US20130330274A1 (en) Compositions and methods for detecting and treating cancer
HRP20231525T1 (hr) Postupci i pripravci za dijagnozu i liječenje raka
JP6602034B2 (ja) 標的化分子およびその使用
US11160887B2 (en) Compositions for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
CN118576733A (zh) 靶向蛋白造影剂、其制备方法及用途
RU2012157597A (ru) Rhamm-связывающие пептиды
JP6186371B2 (ja) 患者選別方法
Feng et al. Multi-modal imaging probe for glypican-3 overexpressed in orthotopic hepatocellular carcinoma
US11890352B2 (en) Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer
JP2012524079A5 (https=)
TW201106964A (en) A motilin-link peptide compound offering absorptivity via mucous administration
US20180179543A1 (en) Device and method to treat esophageal disorders
US11795197B2 (en) Peptide compositions for immuno-oncology molecular imaging and targeted drug delivery
Nakamura et al. Improvement of biodistribution profile of a radiogallium-labeled, αvβ6 integrin-targeting peptide probe by incorporation of negatively charged amino acids
US10421786B2 (en) Peptides that target inflamed or distressed cardiac tissue and uses related thereto
JP2012525121A5 (https=)
Gupta et al. WJG
JP2014037395A (ja) 放射性ヨウ素により標識された標識化合物
HK1234666B (en) Bi-terminal pegylated integrin-binding peptides and methods of use thereof
HK1234666A1 (en) Bi-terminal pegylated integrin-binding peptides and methods of use thereof
Cuthbertson et al. Molecular Probes for Visualizing Angiogenesis
RU2012157289A (ru) Способ терапии злокачественной опухоли